glp 1 drugs fda approved GLP-1 Medications for Weight Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness FDA Says to Drop Suicide
Description
In October, FDA granted fast track status to Mounjaro as a treatment for obesity
Serious adverse effects are rare but require immediate medical attention
Pharmaceutical Benefits Scheme (PBS)
In a study published in JAMA Network Open in January 2025, which included more than 125,000 patients, nearly 65 percent of those taking GLP1s for reasons other than Type 2 diabetes discontinued them within one year
It is not intended for human consumption, diagnostic, or therapeutic use
FDA Approves Treatment for Serious Liver Disease Known as MASH
